Litcius/Paper detail

Development of Meropenem Resistance in a Multidrug-Resistant Campylobacter coli Strain Causing Recurrent Bacteremia in a Hematological Malignancy Patient

María Bonilla-Moreno, Miriam Torrecillas, Júlia Laporte-Amargós, Aída González-Díaz, Alberto Mussetti, Fé Tubau, Carlota Gudiol, M.Á. Domínguez, Sara Martí, Graciela Rodríguez-Sevilla, Carmen Ardanuy

2023Antimicrobial Agents and Chemotherapy11 citationsDOIOpen Access PDF

Abstract

Campylobacter bacteremia is an uncommon disease that mainly occurs in immunocompromised patients and is associated with antibiotic resistance, particularly in Campylobacter coli. We report a patient with persistent blood infection because of a multidrug-resistant (MDR) C. coli strain over a 3-month period. Through this period monotherapy with meropenem was associated with the development of resistance to it. Improving immunity status and a combined therapy for intestinal decolonization were useful to control persistent C. coli infection in this patient.

Topics & Concepts

BacteremiaMultiple drug resistanceMeropenemCampylobacterMicrobiologyAntibioticsMedicineAntibiotic resistanceBiologyBacteriaGeneticsSalmonella and Campylobacter epidemiologyAntibiotic Resistance in BacteriaEscherichia coli research studies
Development of Meropenem Resistance in a Multidrug-Resistant Campylobacter coli Strain Causing Recurrent Bacteremia in a Hematological Malignancy Patient | Litcius